Guardant Health, Inc.
Methods for computer processing sequence reads to detect molecular residual disease

Abstract:

Disclosed herein are methods for use in detection of molecular residual disease. The methods may comprise deep sequencing a panel of genomic regions in cell-free DNA molecules and computer processing sequence reads to detect variants that are indicative of molecular residual disease.